Amal Reports Q2 Revenue Growth To ₹130 Crore As EBITDA Margins Contract

Market snapshot: Amal Ltd reported its Q2 financial performance with a substantial rise in consolidated revenue to ₹130 crore from ₹54 crore in the year-ago period. However, operating profit margins contracted sharply to 6.45% from 15.93% YoY, resulting in a flat net profit of ₹6.2 crore.

Data Snapshot

• Consolidated revenue expanded to ₹130 crore from ₹54 crore in the corresponding prior-year quarter
• Consolidated net profit reached ₹6.2 crore compared to ₹6.1 crore YoY
• EBITDA stood at ₹8.5 crore versus ₹8.6 crore in the year-ago quarter
• EBITDA margin contracted to 6.45% from 15.93% YoY

What's Changed

• Top-line consolidated revenue increased to ₹130 crore from ₹54 crore YoY.
• EBITDA margin contracted by 948 basis points to 6.45% from 15.93% YoY.

Key Takeaways

• Top-line expansion drove consolidated revenue to ₹130 crore.
• Bottom-line growth remained muted as net profit held at ₹6.2 crore versus ₹6.1 crore YoY.
• Operating profit margins experienced significant compression from 15.93% to 6.45%.

SAHI Perspective

Amal's significant top-line gains demonstrate healthy revenue conversion, but the substantial compression in operating margins underscores cost pressure. Investors should evaluate whether operating leverage can normalize as capacity expansions take effect.

Market Implications

The market may weigh robust revenue growth against squeezed operating profitability, keeping price action grounded until EBITDA margins stabilize.

Trading Signals

Market Bias: Neutral

Robust revenue expansion to ₹130 crore is balanced by margin compression to 6.45% and stagnant net profit of ₹6.2 crore, pointing to a neutral near-term outlook.

Overweight: Specialty Chemicals (Revenue Scale)

Underweight: Specialty Chemicals (Operating Margins)

Trigger Factors:

• Sequential trajectory of EBITDA margins in coming quarters
• Raw material price trends in bulk and specialty chemicals
• Execution progress on SO2 capacity expansion project

Time Horizon: Near-term (0-3 months)

Industry Context

Specialty chemical manufacturers have navigated input cost volatility, leading to margin compression across the sector despite higher volume sales.

Key Risks to Watch

• Persistent raw material inflation squeezing operating margins further
• Inability to pass through cost escalations to end customers

Recent Developments

In July 2026, Amal Ltd approved a capital expenditure proposal to expand its production capacity of Sulphur Dioxide (SO2) from 45 tpd to 105 tpd.

Closing Insight

While top-line growth highlights strong product uptake, operational efficiency and margin stability will dictate net earnings growth going forward.

High Performance Trading with SAHI.